Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 10/15/2026 | Verkauf | 112.71 | 2,642 | 297,780 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 10/15/2026 | Optionsausübung | 64.25 | 925 | 59,431 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 10/15/2026 | Optionsausübung | 61.18 | 455 | 27,837 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 10/15/2026 | Optionsausübung | 61.76 | 423 | 26,124 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 10/15/2026 | Optionsausübung | 71.93 | 839 | 60,349 | Form 4 |
| INCY | Heeson Lee | EVP, Head of Incyte Intl | 10/01/2026 | Steuer-Abgabe | 117.14 | 463 | 54,236 | Form 4 |
| INCY | Clancy Paul J | Director | 09/30/2026 | Zuteilung | 121.35 | 203 | 24,634 | Form 4 |
| INCY | Baker Bros. Advisors Lp | Director | 09/30/2026 | Zuteilung | — | 322 | — | Form 4 |
| INCY | Harrigan Edmund | Director | 09/30/2026 | Zuteilung | 121.35 | 206 | 24,998 | Form 4 |
| INCY | Gardner David H | EVP, Chief Strategy Officer | 09/22/2026 | Steuer-Abgabe | 126.93 | 920 | 116,776 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 09/15/2026 | Verkauf | 120.49 | 13,985 | 1,685,053 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 09/15/2026 | Verkauf | 120.50 | 9,233 | 1,112,577 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 09/15/2026 | Optionsausübung | 71.93 | 9,233 | 664,130 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 09/15/2026 | Optionsausübung | 64.25 | 6,477 | 416,147 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 09/15/2026 | Optionsausübung | 61.18 | 4,551 | 278,430 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 09/15/2026 | Optionsausübung | 61.76 | 2,957 | 182,624 | Form 4 |
| INCY | Basi Ramitpal K | EVP, Human Resources | 08/25/2026 | Steuer-Abgabe | 129.72 | 504 | 65,379 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 08/19/2026 | Verkauf | 125.56 | 10,801 | 1,356,174 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 08/12/2026 | Verkauf | 120.04 | 10,803 | 1,296,792 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 08/05/2026 | Verkauf | 123.99 | 2,207 | 273,646 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 08/05/2026 | Optionsausübung | 106.47 | 2,207 | 234,979 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 08/05/2026 | Verkauf | 122.69 | 10,640 | 1,305,422 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 08/03/2026 | Verkauf | 120.43 | 6,055 | 729,204 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 08/03/2026 | Optionsausübung | 105.43 | 6,055 | 638,379 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.41 | 2,293 | 273,807 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 121.69 | 326 | 39,671 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 122.19 | 85 | 10,386 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.38 | 1,642 | 196,022 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.51 | 1,643 | 196,355 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.40 | 2,864 | 341,962 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.39 | 4,695 | 560,536 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.43 | 6,171 | 737,003 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.47 | 2,187 | 261,281 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.42 | 5,332 | 636,747 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Verkauf | 119.46 | 14,661 | 1,751,403 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 105.43 | 326 | 34,370 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 106.47 | 85 | 9,050 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 90.56 | 2,293 | 207,654 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 85.01 | 1,642 | 139,586 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 83.20 | 3,023 | 251,514 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 80.50 | 1,643 | 132,262 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 77.67 | 2,864 | 222,447 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 83.58 | 2,623 | 219,230 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 72.27 | 9,459 | 683,602 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 71.93 | 2,072 | 149,039 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 68.62 | 3,148 | 216,016 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 61.76 | 2,709 | 167,308 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 64.25 | 2,284 | 146,747 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/31/2026 | Optionsausübung | 61.18 | 2,918 | 178,523 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 07/31/2026 | Verkauf | 119.70 | 15,888 | 1,901,794 | Form 4 |
| INCY | Hoffman Richard A. | EVP & General Counsel | 07/16/2026 | Zuteilung | — | 7,395 | — | Form 4 |
| INCY | Gardner David H | EVP, Chief Strategy Officer | 07/16/2026 | Zuteilung | — | 7,395 | — | Form 4 |
| INCY | Basi Ramitpal K | EVP, Human Resources | 07/16/2026 | Zuteilung | — | 4,991 | — | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 07/16/2026 | Zuteilung | — | 5,916 | — | Form 4 |
| INCY | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | 07/16/2026 | Zuteilung | — | 7,857 | — | Form 4 |
| INCY | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | 07/16/2026 | Verkauf | 115.01 | 1,093 | 125,706 | Form 4 |
| INCY | Tray Thomas | Principal Accounting Officer | 07/16/2026 | Zuteilung | — | 2,834 | — | Form 4 |
| INCY | Stein Steven H | CMO & Head of Late-Stage Dev. | 07/16/2026 | Zuteilung | — | 9,798 | — | Form 4 |
| INCY | Stein Steven H | CMO & Head of Late-Stage Dev. | 07/16/2026 | Verkauf | 114.73 | 1,877 | 215,348 | Form 4 |
| INCY | Meury William | Chief Executive Officer | 07/16/2026 | Zuteilung | — | 26,807 | — | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).